SEC Form 4 · accession 0001078782-18-000735
Zivo Bioscience, Inc. · ZIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher D. Maggiore
Director · 10% Owner
Period of report
Jul 20, 2018
Accepted (ET)
Jul 26, 2018 · 2:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001101026
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 20, 2018 | P | 5,000 | $0.12 | A | 14,813,831 | D | |
| Common Stock | Jul 20, 2018 | P | 5,000 | $0.13 | A | 14,818,831 | D |
Table II — derivative securities
No Table II lines on this filing.